Curaleaf Holdings (CURLF) Invested Capital (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Invested Capital of $156.1 million for Q4 2025, down 3.43% year-over-year from $161.7 million in Q4 2024, and down 3.43% quarter-over-quarter from $161.7 million in Q4 2024.
Curaleaf Holdings (CURLF) Invested Capital (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Invested Capital history runs 7 years deep, the most recent figure standing at $156.1 million for Q4 2025.
- In Q4 2025, Invested Capital fell 3.43% year-over-year to $156.1 million; the TTM figure through Mar 2026 stood at $156.1 million (down 11.82% YoY), while the FY2025 annual figure was $156.1 million, down 3.43% from the prior year.
- Invested Capital for Q4 2025 stood at $156.1 million, down from $161.7 million in the prior quarter.
- The five-year high for Invested Capital was $28.8 billion in Q1 2022, with the low at $4.2 million in Q1 2021.
- The 5-year median for Invested Capital is $23.5 million (2022), against an average of $2.0 billion.
- The sharpest annual moves came in 2022 and 2024: Invested Capital jumped 686926.0% in 2022, then slumped 90.82% in 2024.
- Curaleaf Holdings' Invested Capital stood at $9.2 million in 2021, then soared by 1819.73% to $175.8 million in 2022, then slipped by 3.62% to $169.4 million in 2023, then retreated by 4.55% to $161.7 million in 2024, then declined by 3.43% to $156.1 million in 2025.
- Business Quant data shows CURLF's Invested Capital at $156.1 million in Q4 2025, $161.7 million in Q4 2024, and $5.7 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn | 167.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 167.68 Mn |
| Dec 31, 2025 | 156.13 Mn |
| Dec 31, 2024 | 161.68 Mn |
| Sep 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 9.67 Mn |
| Dec 31, 2023 | 169.39 Mn |
| Sep 30, 2023 | 62.25 Mn |
| Jun 30, 2023 | 48.47 Mn |
| Dec 31, 2022 | 175.75 Mn |
| Sep 30, 2022 | 23.48 Mn |
| Jun 30, 2022 | 20.96 Mn |
| Mar 31, 2022 | 28.81 Bn |
| Dec 31, 2021 | 9.16 Mn |
| Sep 30, 2021 | 9.16 Mn |
| Jun 30, 2021 | 9.16 Mn |
| Mar 31, 2021 | 4.19 Mn |
| Dec 31, 2020 | 6.50 Mn |
| Sep 30, 2020 | 9.70 Mn |
| Dec 31, 2019 | 17.00 Mn |